These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32967902)

  • 1. Summary of Novel Bacterial Isolates Derived from Human Clinical Specimens and Nomenclature Revisions Published in 2018 and 2019.
    Munson E; Carroll KC
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 32967902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Accepted Novel Bacterial Isolates Derived from Human Clinical Specimens and Taxonomic Revisions Published in 2020 and 2021.
    Munson E; Carroll KC
    J Clin Microbiol; 2023 Jan; 61(1):e0028222. PubMed ID: 36533910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valid and accepted novel bacterial taxa derived from human clinical specimens and taxonomic revisions published in 2022.
    Munson E; Carella A; Carroll KC
    J Clin Microbiol; 2023 Nov; 61(11):e0083823. PubMed ID: 37889007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Novel Taxa and Revised Taxonomic Status of Bacteria Isolated from Domestic Animals Described in 2018 to 2021.
    Munson E; Lawhon SD; Burbick CR; Zapp A; Villaflor M; Thelen E
    J Clin Microbiol; 2023 Feb; 61(2):e0028122. PubMed ID: 36533907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on the Novel Genera and Species and Revised Taxonomic Status of Bacterial Organisms Described in 2016 and 2017.
    Munson E; Carroll KC
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30257907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Novel Taxa and Revised Taxonomic Status of Bacteria Isolated from Nondomestic Animals Described in 2018 to 2021.
    Lawhon SD; Burbick CR; Munson E; Zapp A; Thelen E; Villaflor M
    J Clin Microbiol; 2023 Feb; 61(2):e0142522. PubMed ID: 36533958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance among
    Lord J; Gikonyo A; Miwa A; Odoi A
    PeerJ; 2021; 9():e11958. PubMed ID: 34557345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2149-52. PubMed ID: 15155214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's in a Name? New Bacterial Species and Changes to Taxonomic Status from 2012 through 2015.
    Munson E; Carroll KC
    J Clin Microbiol; 2017 Jan; 55(1):24-42. PubMed ID: 27795334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial systematics and taxonomy: relevance for a microbial commons.
    Moore ER; Mihaylova SA; Vandamme P; Krichevsky MI; Dijkshoorn L
    Res Microbiol; 2010; 161(6):430-8. PubMed ID: 20670913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokaryotic taxonomy and nomenclature in the age of big sequence data.
    Hugenholtz P; Chuvochina M; Oren A; Parks DH; Soo RM
    ISME J; 2021 Jul; 15(7):1879-1892. PubMed ID: 33824426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on novel taxa and revised taxonomic status of bacteria isolated from non-domestic animals described in 2022.
    Burbick CR; Lawhon SD; Munson E; Thelen E; Zapp A; Wilson A
    J Clin Microbiol; 2023 Dec; 61(12):e0084023. PubMed ID: 37888990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the name really matter? The importance of botanical nomenclature and plant taxonomy in biomedical research.
    Bennett BC; Balick MJ
    J Ethnopharmacol; 2014 Mar; 152(3):387-92. PubMed ID: 24321863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of cyanobacterial nomenclature under the "prokaryotic" and the "botanical" code.
    Oren A; Ventura S
    Antonie Van Leeuwenhoek; 2017 Oct; 110(10):1257-1269. PubMed ID: 28243951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public discussion on a proposed revision of the International Code of Nomenclature of Prokaryotes.
    Oren A; Arahal DR; Rosselló-Móra R; Sutcliffe IC; Moore ERB
    Int J Syst Evol Microbiol; 2021 Jun; 71(6):. PubMed ID: 34191704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.
    Chavda KD; Chen L; Fouts DE; Sutton G; Brinkac L; Jenkins SG; Bonomo RA; Adams MD; Kreiswirth BN
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmonizing Prokaryotic Nomenclature: Fixing the Fuss over Phylum Name Flipping.
    Panda A; Islam ST; Sharma G
    mBio; 2022 Jun; 13(3):e0097022. PubMed ID: 35536003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Enterobacteriaceae spp. and its multidrug-resistant rates in clinical isolates: A two-center cross-sectional study.
    Mirzaei B; Babaei R; Bazgir ZN; Goli HR; Keshavarzi S; Amiri E
    Mol Biol Rep; 2021 Jan; 48(1):665-675. PubMed ID: 33389531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.